Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 67,347 shares at $10.38 ($710K) on 2023-12-04, disclosed to the SEC on 2023-12-06.
Open-market purchase of $710k PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.38 | 27,000 | $280K | 39.5% |
| 2 | $10.66 | 20,000 | $213K | 30.0% |
| 3 | $10.66 | 20,347 | $217K | 30.5% |
| Total | $10.55 avg | 67,347 | $710K | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |